We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.25%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$89.6B
AUM Growth
-$4.64B
(-4.9%)
Cap. Flow
-$5.94B
Cap. Flow
% of AUM
-6.62%
Top 10 Holdings %
Top 10 Hldgs %
12.99%
Holding
2,276
New
117
Increased
853
Reduced
1,022
Closed
220
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$322M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$260M |
| 3 |
Cummins
CMI
|
+$246M |
| 4 |
Wells Fargo
WFC
|
+$242M |
| 5 |
Eli Lilly
LLY
|
+$177M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$334M |
| 2 |
RTN
Raytheon Company
RTN
|
+$310M |
| 3 |
Micron Technology
MU
|
+$306M |
| 4 |
Valero Energy
VLO
|
+$301M |
| 5 |
HF Sinclair
DINO
|
+$289M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.11% |
| 2 | Healthcare | 17.02% |
| 3 | Consumer Discretionary | 12.05% |
| 4 | Financials | 11.02% |
| 5 | Industrials | 10.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Corcept Therapeutics
CORT
$12B
| $2.24M | ﹤0.01% |
201,062
+46,874
| +30% | +$522K |
|
1227
LKQ Corp
LKQ
$6.29B
| $2.24M | ﹤0.01% |
84,704
+2,833
| +3% | +$79.3K |
|
1228
Rapid7
RPD
$773M
| $2.24M | ﹤0.01% |
38,664
-6,052
| -14% | -$318K |
|
1229
Insmed
INSM
$28.6B
| $2.23M | ﹤0.01% |
87,198
+5,734
| +7% | +$160K |
|
1230
Antero Resources
AR
$10.7B
| $2.23M | ﹤0.01% |
415,266
+397,535
| +2,242% | +$2.87M |
|
1231
Enphase Energy
ENPH
$5.53B
| $2.23M | ﹤0.01% |
122,109
-140,872
| -54% | -$1.94M |
|
|
MDSO
1232
DELISTED
Medidata Solutions, Inc.
MDSO
| $2.21M | ﹤0.01% |
24,400
+19,551
| +403% | +$1.72M |
|
|
AXON
1233
Axon Enterprise
AXON
$46.4B
| $2.21M | ﹤0.01% |
34,377
-25,113
| -42% | -$1.64M |
|
1234
Peabody Energy
BTU
$2.9B
| $2.19M | ﹤0.01% |
90,796
+72,702
| +402% | +$1.91M |
|
|
CONE
1235
DELISTED
CyrusOne Inc Common Stock
CONE
| $2.19M | ﹤0.01% |
37,894
-912
| -2% | -$53.5K |
|
|
FOLD
1236
DELISTED
Amicus Therapeutics
FOLD
| $2.17M | ﹤0.01% |
173,602
| – | – |
|
1237
Financial Institutions
FISI
$821M
| $2.16M | ﹤0.01% |
74,218
-29,718
| -29% | -$828K |
|
|
TBRG
1238
DELISTED
TruBridge
TBRG
| $2.16M | ﹤0.01% |
77,640
+31,751
| +69% | +$887K |
|
|
ESGR
1239
DELISTED
Enstar Group
ESGR
| $2.15M | ﹤0.01% |
12,325
-2,179
| -15% | -$378K |
|
|
MSGN
1240
DELISTED
MSG Networks Inc.
MSGN
| $2.13M | ﹤0.01% |
102,672
-62,132
| -38% | -$1.36M |
|
1241
Williams Companies
WMB
$86.1B
| $2.12M | ﹤0.01% |
76,286
+23,531
| +45% | +$654K |
|
1242
MYR Group
MYRG
$5.25B
| $2.12M | ﹤0.01% |
56,813
+4,343
| +8% | +$151K |
|
1243
Allegion
ALLE
$14.4B
| $2.12M | ﹤0.01% |
19,150
+1,453
| +8% | +$145K |
|
1244
Axos Financial
AX
$5.68B
| $2.12M | ﹤0.01% |
77,655
-26,953
| -26% | -$793K |
|
1245
Spok Holdings
SPOK
$241M
| $2.11M | ﹤0.01% |
140,469
+46,987
| +50% | +$697K |
|
1246
Innoviva
INVA
$1.48B
| $2.1M | ﹤0.01% |
144,047
-28,359
| -16% | -$402K |
|
|
CSLT
1247
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $2.09M | ﹤0.01% |
645,824
+221,890
| +52% | +$764K |
|
1248
National Health Investors
NHI
$3.65B
| $2.08M | ﹤0.01% |
26,696
+349
| +1% | +$27.1K |
|
1249
LXP Industrial Trust
LXP
$3.57B
| $2.08M | ﹤0.01% |
44,198
-3,477
| -7% | -$160K |
|
1250
Onto Innovation
ONTO
$15.3B
| $2.08M | ﹤0.01% |
59,809
-35,660
| -37% | -$1.14M |
|
Similar funds
VGA
AQR Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, AQR Capital Management held 2,276 positions worth $89.6B, down 4.9% from $94.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management withdrew a net $5.94B in Q2 2019, closing 220 positions and reducing 1,022 holdings. Its most notable exit was Stellantis, an estimated $334M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, AQR Capital Management opened a new position in Optimum Communications Inc worth $28.8M.
- AQR Capital Management's largest Q2 2019 buy was Optimum Communications Inc: 1,190,376 shares worth $28.8M.
- AQR Capital Management added most to Procter & Gamble in Q2 2019, an estimated $322M increase.
- AQR Capital Management's biggest Q2 2019 reduction was Raytheon Company, cutting an estimated $310M.
- AQR Capital Management fully exited Stellantis in Q2 2019, selling an estimated $334M.
- AQR Capital Management's ten largest holdings make up 13% of its $89.6B portfolio in Q2 2019.
- AQR Capital Management opened 117 new positions and closed 220 in Q2 2019.
- AQR Capital Management's portfolio value fell 4.9% quarter-over-quarter to $89.6B.
Based on AQR Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.